Application of cold chain positioning system in transport of neonatal inherited metabolic disease screening samples
WU Cuilu, YANG Jianbin, XU Yihong, XU Yanhua, YANG Rulai, MAO Huaqing
Department of Genetics and Metabolism, Children's Hospital Affiliated to Zhejiang University School of Medicine(National Clinical Research Center for Child Health), Hangzhou, Zhejiang 310052, China
Abstract：Transport of filter paper-dried blood spot samples is a critical procedure during the screening of neonatal inherited metabolic diseases, which is of great significance for the screening accuracy. In order to ensure the timing and safety of sample transport, the cold chain positioning system was initiated by Zhejiang Provincial Center for Quality Control of Neonatal Disease Screening since March 2015. Based on the framework of neonatal disease screening information management system, the function of the logistics transport management system was included in this positioning system, with aims to achieve the monitoring and tracking of sample transport processes through real-time positioning of the sample transport box via China Unicom 4G logistics card and global positioning system/BeiDou Navigation Satellite System. The samples are maintained in a transport environment at 2 to 8 °C via the temperature-controlled box made of 5 °C phase-changed cold-stored materials and general packet radio service (GPRS) temperature recorders. The mean pretest turnover duration reduced from 8.44 days to 5.03 days following introduction of the cold chain positioning system, and the percentage of timely sample delivery increased from 31.69% to 77.90%, while the withdrawal rate of unqualified samples reduced from 0.12% to 0.08%. The cold chain positioning system meets the requirements of transport of filter paper-dried blood spot samples, which has a high potential in screening of neonatal inherited metabolic diseases.
[1] 尚世强,杨建滨,王治国.新生儿遗传代谢病串联质谱筛查存在的问题及展望[J].中华检验医学杂志,2016,39(4):237-239. SHANG S Q,YANG J B,WANG Z G.Current problems and prospect on tandem mass spectrometry based newborn inherited metabolic diseases screening[J].Chin J Lab Med,2016,39(4):237-239. [2] 胡凌微,胡真真,杨建滨,等.递送及储存条件对新生儿干血斑标本中氨基酸和肉碱浓度的影响[J].浙江大学学报(医学版),2020,49(5):565-573. HU L W,HU Z Z,YANG J B,et al.Effect of delivery and storage conditions on concentrations of amino acids and carnitines in neonatal dried blood spots[J].J Zhejiang Univ (Med Sci),2020,49(5):565-573. [3] 赵正言,顾学范.新生儿遗传代谢病筛查(第2版)[M].北京:人民卫生出版社,2015:10. ZHAO Z Y,GU X F.Newborn genetic metabolic diseases screening(2nd edition)[M].Beijing:People's Medical Publishing House,2015:10. [4] 冯春颜,夏勇武,汪宇英,等.临床检验标本运送方式现状及解决方案[J].检验医学与临床,2016,13(12):1674-1675. FENG C Y,XIA Y W,WANG Y Y,et al.Current situation and solutions of transportation of clinical specimens[J].Lab Med Clin,2016,13(12):1674-1675. [5] 王绍鑫,李汉超,秦晓东,等.病原微生物实验室生物样本运输安全现状调研及其对策[J].中国卫生监督杂志,2018,25(2):122-127. WANG S X,LI H C,QIN X D,et al.The status investigation and countermeasure on the transportation security of pathogenic microorganism biological sample[J].Chin J Health Inspection,2018,25(2):122-127. [6] 蒋征刚,胡崇高,郑银霜,等.生物样本运输定位追溯系统的研发及应用[J].预防医学,2020,32(7):753-756. JIANG Z G,HU C G,ZHENG Y S,et al.Development and application of a biological sample positioning and tracing system[J].Prev Med,2020,32(7):753-756. [7] 中华人民共和国卫生部.新生儿疾病筛查技术规范(2010版)[Z/OL].(2010-11-10) [2020-06-17].http://www.nhc.gov.cn/cmsresources/mohfybjysqwss/cmsrsdocument/doc10798.doc. [8] 国家卫生计生委临床检验中心新生儿遗传代谢病筛查实验室专家组.新生儿遗传代谢病筛查质量指标共识[J].中华检验医学杂志,2017,40(5):352-355. Laboratory Expert Group of Neonatal Genetic and Metabolic Disease Screening,Clinical Test Center,National Health and Family Planning Commission of the People's Republic of China.Consensus on indicators of inherited metabolic disease screening quality in newborns[J].Chin J Lab Med,2017,40(5):352-355. [9] 刘英莲. 临床检验标本运送的安全管理[J].实用妇科内分泌电子杂志,2017,4(24):47-48. LIU Y L.Security management of clinical specimen transportation[J].Electron J Pract Gynecol Endocrinol,2017,4(24):47-48. [10] 魏鹏燕. 中国卫生标准体系及制度发展回顾[J].中国卫生标准管理,2019,10(14):168. WEI P Y.Review of system and regulation development of health standard in China[J].China Health Stand Manag,2019,10(14):168.
